Healios K.K. Statistics
Total Valuation
Healios K.K. has a market cap or net worth of JPY 26.97 billion. The enterprise value is 23.29 billion.
Important Dates
The last earnings date was Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Healios K.K. has 135.55 million shares outstanding. The number of shares has increased by 26.34% in one year.
| Current Share Class | 135.55M |
| Shares Outstanding | 135.55M |
| Shares Change (YoY) | +26.34% |
| Shares Change (QoQ) | -7.03% |
| Owned by Insiders (%) | 20.72% |
| Owned by Institutions (%) | 5.12% |
| Float | 72.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 591.21 |
| PB Ratio | 4.17 |
| P/TBV Ratio | 12.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.56.
| Current Ratio | 1.73 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.16% and return on invested capital (ROIC) is -186.43%.
| Return on Equity (ROE) | -54.16% |
| Return on Assets (ROA) | -15.31% |
| Return on Invested Capital (ROIC) | -186.43% |
| Return on Capital Employed (ROCE) | -27.56% |
| Weighted Average Cost of Capital (WACC) | 10.11% |
| Revenue Per Employee | 626,667 |
| Profits Per Employee | -34.84M |
| Employee Count | 75 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Healios K.K. has paid 435.00 million in taxes.
| Income Tax | 435.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.21% in the last 52 weeks. The beta is 1.31, so Healios K.K.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -55.21% |
| 50-Day Moving Average | 272.94 |
| 200-Day Moving Average | 311.34 |
| Relative Strength Index (RSI) | 28.40 |
| Average Volume (20 Days) | 1,565,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healios K.K. had revenue of JPY 47.00 million and -2.61 billion in losses. Loss per share was -27.18.
| Revenue | 47.00M |
| Gross Profit | -29.00M |
| Operating Income | -4.92B |
| Pretax Income | -2.18B |
| Net Income | -2.61B |
| EBITDA | -4.61B |
| EBIT | -4.92B |
| Loss Per Share | -27.18 |
Full Income Statement Balance Sheet
The company has 7.42 billion in cash and 3.72 billion in debt, with a net cash position of 3.70 billion or 27.33 per share.
| Cash & Cash Equivalents | 7.42B |
| Total Debt | 3.72B |
| Net Cash | 3.70B |
| Net Cash Per Share | 27.33 |
| Equity (Book Value) | 6.68B |
| Book Value Per Share | 49.19 |
| Working Capital | 3.62B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -4.92 billion and capital expenditures -309.00 million, giving a free cash flow of -5.23 billion.
| Operating Cash Flow | -4.92B |
| Capital Expenditures | -309.00M |
| Depreciation & Amortization | 311.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -5.23B |
| FCF Per Share | -38.56 |
Full Cash Flow Statement Margins
| Gross Margin | -61.70% |
| Operating Margin | -10,461.70% |
| Pretax Margin | -4,627.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Healios K.K. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.34% |
| Shareholder Yield | -26.34% |
| Earnings Yield | -13.66% |
| FCF Yield | -18.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for Healios K.K. is 798.17, which is 301.09% higher than the current price. The consensus rating is "Buy".
| Price Target | 798.17 |
| Price Target Difference | 301.09% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 128.98% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healios K.K. has an Altman Z-Score of 1.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.06 |
| Piotroski F-Score | 3 |